Its anti-tumor mechanisms involve the regulation of multiple signaling pathways, such as phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR), nuclear factor kappa B (NF-κB), Wnt (wingless/integration 1)/β-catenin, mitogen-activated protein kinases (MAPKs) (Lin et al., 2022). Here, AKT1 is linked to neoplasm.